Bellesi S - Search Results

1

The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI).

Annibali O, Hohaus S, Marchesi F, Cantonetti M, Di Rocco A, Tomarchio V, Di Napoli A, Pelliccia S, Battistini R, Anticoli Borza P, Abruzzese E, Cenfra N, Andriani A, Tesei C, Alma E, Palombi F, Pupo L, Petrucci L, Becilli M, Maiolo E, Bellesi S, Cuccaro A, D'Alò F, Cox MC. Annibali O, et al. Among authors: bellesi s. Leuk Lymphoma. 2019 Dec;60(14):3386-3394. doi: 10.1080/10428194.2019.1633628. Epub 2019 Jul 1. Leuk Lymphoma. 2019. PMID: 31259651

2

Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.

Di Mario A, Garzia M, d'Alò F, Rumi C, Massini G, Bellesi S, Zini G. Di Mario A, et al. Among authors: bellesi s. Hematology. 2007 Apr;12(2):155-7. doi: 10.1080/10245330600938398. Hematology. 2007. PMID: 17454197 No abstract available.

3

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.

Chiusolo P, Giammarco S, Bellesi S, Metafuni E, Piccirillo N, De Ritis D, Marietti S, Federica S, Laurenti L, Fianchi L, Hohaus S, Giuseppe L, Sica S. Chiusolo P, et al. Among authors: bellesi s. Cancer Chemother Pharmacol. 2012 Mar;69(3):691-6. doi: 10.1007/s00280-011-1751-4. Epub 2011 Oct 9. Cancer Chemother Pharmacol. 2012. PMID: 21984221

4

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies.

Fabiani E, Falconi G, Fianchi L, Guidi F, Bellesi S, Voso MT, Leone G, D'Alò F. Fabiani E, et al. Among authors: bellesi s. Exp Hematol. 2014 Sep;42(9):731-3. doi: 10.1016/j.exphem.2014.04.011. Epub 2014 May 4. Exp Hematol. 2014. PMID: 24796317 Free article. No abstract available.

5

Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.

Bozzoli V, Tisi MC, Maiolo E, Alma E, Bellesi S, D'Alo' F, Voso MT, Leone G, Hohaus S. Bozzoli V, et al. Among authors: bellesi s. Br J Haematol. 2015 Jun;169(6):787-94. doi: 10.1111/bjh.13358. Epub 2015 Mar 29. Br J Haematol. 2015. PMID: 25819007 Free article. Clinical Trial.

6

Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.

Tisi MC, Cupelli E, Santangelo R, Maiolo E, Alma E, Giachelia M, Martini M, Bellesi S, D'Alò F, Voso MT, Pompili M, Leone G, Larocca LM, Hohaus S. Tisi MC, et al. Among authors: bellesi s. Leuk Lymphoma. 2016;57(3):628-34. doi: 10.3109/10428194.2015.1072766. Epub 2015 Oct 12. Leuk Lymphoma. 2016. PMID: 26458141

7

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CS, Bellesi S, Hohaus S, Voso MT, D'Alò F, Leone G. Falconi G, et al. Among authors: bellesi s. Exp Hematol. 2016 Jan;44(1):75-83.e1-4. doi: 10.1016/j.exphem.2015.10.005. Epub 2015 Oct 28. Exp Hematol. 2016. PMID: 26521017 Free article.

8

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience.

Laurenti L, Autore F, Innocenti I, D'Arena G, Coscia M, Mondello P, Chiusolo P, Bellesi S, Efremov DG, Sica S, Mauro FR. Laurenti L, et al. Among authors: bellesi s. Leuk Lymphoma. 2016 Oct;57(10):2429-31. doi: 10.3109/10428194.2015.1137293. Epub 2016 Jan 27. Leuk Lymphoma. 2016. PMID: 26818825 No abstract available.

9

Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy.

Hohaus S, Tisi MC, Bellesi S, Maiolo E, Alma E, Tartaglia G, Corrente F, Cuccaro A, D'Alo' F, Basile U, Larocca LM, De Stefano V. Hohaus S, et al. Among authors: bellesi s. Cancer Med. 2018 Jan;7(1):270-281. doi: 10.1002/cam4.1166. Epub 2017 Dec 22. Cancer Med. 2018. PMID: 29271084 Free PMC article.

10

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization.

Hohaus S, Tisi MC, Bartolomei F, Cuccaro A, Maiolo E, Alma E, D'Alò F, Bellesi S, Rossi E, De Stefano V. Hohaus S, et al. Among authors: bellesi s. Blood Cancer J. 2018 Jun 7;8(6):54. doi: 10.1038/s41408-018-0096-1. Blood Cancer J. 2018. PMID: 29884791 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page